Athanase Millogo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Athanase Millogo has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Christian Napon
Department of Neurology, University Hospital of Bogodogo, Ouagadougou, Burkina Faso
9 shared publications - Alfred Anselme Dabilgou
Department of Neurology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
6 shared publications - Jean Kaboré
Health Sciences Research Institute, National Center for Scientific and Technological Research, Ouagadougou, Burkina Faso
5 shared publications - Jeoffray Diendéré
Unité de Nutrition, Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), 399, Avenue de la Liberté, 01 BP 545, Bobo-Dioulasso, Burkina Faso
5 shared publications - Alassane Dravé
Department of Neurology, Regional University Hospital of Ouahigouya, Ouahigouya, Burkina Faso
4 shared publications - Hélène Carabin
Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Université de Montréal, Montréal, Canada
4 shared publications
Latest Publications
- 29 September 2026
- Published by MediHealth Academy in Academic Journal of Neuropsychiatry and Neuropsychology
- Vol. 3 (3) , 50-57
Electroclinical aspects of diabetic neuropathy in the city of Ouagadougou
Aims: Diabetic neuropathy (DN) is one of the most common microvascular complications of diabetes mellitus, often leading to severe sensorimotor disability. This study aimed to identify factors associated with the severity of electroneuromyographic (ENMG) involvement among diabetic patients followed in Ouagadougou, Burkina Faso. Methods: We conducted a cross-sectional analytical study including 64 patients with clinically diagnosed DN who underwent electrodiagnostic (EDX) evaluation. Sociodemographic, clinical, and biological data were collected. Neuropathy severity was classified as mild/moderate or severe/very severe. Bivariate and multivariate logistic regression analyses were performed, with a significance level set at p<0.05. Results: The mean age was 64.6±8 years, with a slight female predominance (53.1%). In bivariate analysis, severe EDX involvement was significantly associated with a diabetes duration ≥10 years [OR=6.55; 95% CI (1.95-21.9); p=0.002] and age ≥65 years [OR=3.33; 95% CI (1.15-9.61); p=0.024]. In multivariate analysis, only diabetes duration ≥10 years remained an independent predictor of severity [adjusted OR=5.32; 95% CI (1.52-18.5); p=0.009]. Conclusion: The severity of DN was mainly linked to long-standing diabetes, emphasizing the need for early screening and strict glycemic control.
- 29 September 2026
- Published by MediHealth Academy in Academic Journal of Neuropsychiatry and Neuropsychology
- Vol. 3 (3) , 50-57
Electroclinical aspects of diabetic neuropathy in the city of Ouagadougou
Aims: Diabetic neuropathy (DN) is one of the most common microvascular complications of diabetes mellitus, often leading to severe sensorimotor disability. This study aimed to identify factors associated with the severity of electroneuromyographic (ENMG) involvement among diabetic patients followed in Ouagadougou, Burkina Faso. Methods: We conducted a cross-sectional analytical study including 64 patients with clinically diagnosed DN who underwent electrodiagnostic (EDX) evaluation. Sociodemographic, clinical, and biological data were collected. Neuropathy severity was classified as mild/moderate or severe/very severe. Bivariate and multivariate logistic regression analyses were performed, with a significance level set at p<0.05. Results: The mean age was 64.6±8 years, with a slight female predominance (53.1%). In bivariate analysis, severe EDX involvement was significantly associated with a diabetes duration ≥10 years [OR=6.55; 95% CI (1.95-21.9); p=0.002] and age ≥65 years [OR=3.33; 95% CI (1.15-9.61); p=0.024]. In multivariate analysis, only diabetes duration ≥10 years remained an independent predictor of severity [adjusted OR=5.32; 95% CI (1.52-18.5); p=0.009]. Conclusion: The severity of DN was mainly linked to long-standing diabetes, emphasizing the need for early screening and strict glycemic control.
- 27 June 2026
- Published by MediHealth Academy in Academic Journal of Neuropsychiatry and Neuropsychology
- Vol. 3 (2) , 42-45
Cerebral infarction following snake bite: observation of a case at the Sourô Sanou University Hospital in Bobo-Dioulasso
Snake bites are a public health problem in developing countries. Neurovascular complications are rare. We report a case of cerebral infarction at the Sourô Sanou University Hospital Center in Bobo-Dioulasso complicating a snake bite. The patient was a 44-year-old left-handed man with no cardiovascular risk factors, presenting with left hemiplegia and expressive aphasia two days after a snake bite (reported to be a viper). Cerebral computed tomography (CT) revealed a well-systematized right temporo-parietal cortico-subcortical hypodensity in the deep and superficial territory of the right middle cerebral artery. He received polyvalent antivenom from Vins Bioproducts Ltd and symptomatic treatment from the first day. The outcome was unfavorable, and the patient died on the eighth day after the bite. Cerebral infarction is a rare complication of snake bite envenomation. However, it is responsible for high morbidity and mortality in our context.
- 27 June 2026
- Published by MediHealth Academy in Academic Journal of Neuropsychiatry and Neuropsychology
- Vol. 3 (2) , 42-45
Cerebral infarction following snake bite: observation of a case at the Sourô Sanou University Hospital in Bobo-Dioulasso
Snake bites are a public health problem in developing countries. Neurovascular complications are rare. We report a case of cerebral infarction at the Sourô Sanou University Hospital Center in Bobo-Dioulasso complicating a snake bite. The patient was a 44-year-old left-handed man with no cardiovascular risk factors, presenting with left hemiplegia and expressive aphasia two days after a snake bite (reported to be a viper). Cerebral computed tomography (CT) revealed a well-systematized right temporo-parietal cortico-subcortical hypodensity in the deep and superficial territory of the right middle cerebral artery. He received polyvalent antivenom from Vins Bioproducts Ltd and symptomatic treatment from the first day. The outcome was unfavorable, and the patient died on the eighth day after the bite. Cerebral infarction is a rare complication of snake bite envenomation. However, it is responsible for high morbidity and mortality in our context.
- Open Access
- 16 January 2026
- Published by Science Publishing Group in Clinical Neurology and Neuroscience
- Vol. 10 (1) , 5-14
Management and Progression of Guillain-Barre Syndrome in a Resource-limited Setting: A Multicenter Study in the University Hospitals of Ouagadougou, Burkina Faso
Introduction: Guillain-Barre syndrome (GBS) faces many diagnostic and therapeutic challenges in sub-Saharan Africa, negatively impacting patient prognosis. The aim of this study was to describe the therapeutic and evolutionary modalities of GBS in the university hospitals of Ouagadougou, Burkina Faso. Patients and methods: This was a descriptive cross-sectional study with prospective data collection, conducted in the university hospitals of Ouagadougou (Yalgado Ouedraogo, Tengandogo, Bogodogo) from March 2018 to May 2022. Patients aged ˃ 16 years admitted for GBS according to the modified Brighton criteria were included. Clinical severity at the time of admission and at the end of hospitalization was assessed using the GBS Disability Score (GBSDS). Socio-demographic, clinical, therapeutic, and in-hospital progression data were analyzed. Results: A total of 79 patients were consecutively hospitalized for GBS, with a mean age of 38 years and a male-to-female ratio of 1.25. The mean time to admission was 22 days. The clinical picture consisted of hypo- or areflexic tetraparesis/plegia (100%) with respiratory muscle deficit (44.3%), cranial nerve involvement (58.2%), dysautonomia (55.7%), and albumin-cytological dissociation (100%). ENMG showed demyelinating and axonal forms in 57.6% and 42.4% of cases, respectively. At the plateau phase, 36% and 21% of patients had very severe deficits (Guillain-Barre Syndrome Disability Score (GBSDS 4)) and respiratory distress (GBSDS 5), respectively. Corticosteroid therapy (58.2%) and intravenous immunoglobulins (IVIg) (6.8%) were the specific therapies used. Infectious complications (41.8%), particularly inhalation pneumonia (27.8%), acute respiratory distress (13.9%), and cardiac dysautonomia complications (6.3%), were the most common hospital complications. Eighteen patients (22.8%) were transferred to intensive care, mainly due to the onset of respiratory distress (13.9%). At the end of hospitalization, the hospital mortality rate was 22.8%, with acute respiratory distress (44.4%) and dysautonomic cardiac arrest (16.7%) being the most common immediate causes of death. Conclusion: In Burkina Faso, GBS is confronted with delays in patient admission, low availability and access to IVIG and EP, and high hospital mortality. Early admission and improved access to emergency immunotherapy and intensive care beds in ASS will help improve the prognosis for patients with GBS.
- 16 January 2026
- Published by Science Publishing Group in Clinical Neurology and Neuroscience
- Vol. 10 (1) , 5-14
Open AccessManagement and Progression of Guillain-Barre Syndrome in a Resource-limited Setting: A Multicenter Study in the University Hospitals of Ouagadougou, Burkina Faso
Introduction: Guillain-Barre syndrome (GBS) faces many diagnostic and therapeutic challenges in sub-Saharan Africa, negatively impacting patient prognosis. The aim of this study was to describe the therapeutic and evolutionary modalities of GBS in the university hospitals of Ouagadougou, Burkina Faso. Patients and methods: This was a descriptive cross-sectional study with prospective data collection, conducted in the university hospitals of Ouagadougou (Yalgado Ouedraogo, Tengandogo, Bogodogo) from March 2018 to May 2022. Patients aged ˃ 16 years admitted for GBS according to the modified Brighton criteria were included. Clinical severity at the time of admission and at the end of hospitalization was assessed using the GBS Disability Score (GBSDS). Socio-demographic, clinical, therapeutic, and in-hospital progression data were analyzed. Results: A total of 79 patients were consecutively hospitalized for GBS, with a mean age of 38 years and a male-to-female ratio of 1.25. The mean time to admission was 22 days. The clinical picture consisted of hypo- or areflexic tetraparesis/plegia (100%) with respiratory muscle deficit (44.3%), cranial nerve involvement (58.2%), dysautonomia (55.7%), and albumin-cytological dissociation (100%). ENMG showed demyelinating and axonal forms in 57.6% and 42.4% of cases, respectively. At the plateau phase, 36% and 21% of patients had very severe deficits (Guillain-Barre Syndrome Disability Score (GBSDS 4)) and respiratory distress (GBSDS 5), respectively. Corticosteroid therapy (58.2%) and intravenous immunoglobulins (IVIg) (6.8%) were the specific therapies used. Infectious complications (41.8%), particularly inhalation pneumonia (27.8%), acute respiratory distress (13.9%), and cardiac dysautonomia complications (6.3%), were the most common hospital complications. Eighteen patients (22.8%) were transferred to intensive care, mainly due to the onset of respiratory distress (13.9%). At the end of hospitalization, the hospital mortality rate was 22.8%, with acute respiratory distress (44.4%) and dysautonomic cardiac arrest (16.7%) being the most common immediate causes of death. Conclusion: In Burkina Faso, GBS is confronted with delays in patient admission, low availability and access to IVIG and EP, and high hospital mortality. Early admission and improved access to emergency immunotherapy and intensive care beds in ASS will help improve the prognosis for patients with GBS.
- Open Access
- 7 January 2026
- Vol. 6 (1)
Complications neurologiques de la dengue chez l’adulte dans les CHU de Ouagadougou au cours de l’épidémie de 2023 au Burkina Faso
La dernière épidémie de dengue survenue en 2023 au Burkina Faso a causé la morbimortalité la plus importante d’Afrique. Les complications neurologiques de la dengue sont décrites comme associées à une létalité importante. Nous avons réalisé le présent travail dans le but d’étudier ces complications chez les adultes hospitalisés dans les CHU de Ouagadougou durant l’épidémie de dengue de 2023, au Burkina Faso. Il s’est agi d’une étude transversale, rétrospective, descriptive et analytique, ayant concerné les cas confirmés de dengue chez des adultes hospitalisés du 1er janvier au 31 décembre 2023 dans les CHU de Ouagadougou. La fréquence des complications neurologiques de la dengue, les données sociodémographiques, cliniques, paracliniques et évolutives intrahospitalières de ces patients ont été analysées. Une analyse bivariée puis une étude multivariée selon la méthode de régression logistique multiple ont permis d’identifier les facteurs associés à la létalité intrahospitalière de ces patients. Au total, 1 057 patients ont été hospitalisés pour une dengue dans les CHU de Ouagadougou durant la période épidémique, dont 116 (11 %) ont présenté des complications neurologiques, avec un âge moyen de 47,6 ans et une prédominance féminine (51,7 %). Les troubles de la conscience, les crises épileptiques, les troubles psycho-comportementaux, dans respectivement 84,5 %, 20,7 % et 14,6 % des cas, étaient les signes cliniques neurologiques les plus fréquemment retrouvés. Les complications neurologiques rencontrées étaient les encéphalopathies (7,8 %), les encéphalites probablement dues à la dengue (0,8 %), les accidents vasculaires cérébraux (0,7 %) et le syndrome de Guillain-Barré (0,1 %). La létalité hospitalière a été de 69 % (80 patients) et l’insuffisance rénale aiguë a été le seul facteur indépendant qui lui a été associé (OR = 3,49; p = 0,02). Au Burkina Faso, les complications neurologiques de la dengue sont dominées par les encéphalopa-thies multifactorielles, grevées par une très lourde mortalité. Le dépistage et l’admission précoces dans les unités de soins intensifs ou de réanimation des patients ayant une dengue sévère (avec notamment des signes neurologiques), contribueraient à améliorer leur pronostic.
- 7 January 2026
- Vol. 6 (1)
Open AccessComplications neurologiques de la dengue chez l’adulte dans les CHU de Ouagadougou au cours de l’épidémie de 2023 au Burkina Faso
La dernière épidémie de dengue survenue en 2023 au Burkina Faso a causé la morbimortalité la plus importante d’Afrique. Les complications neurologiques de la dengue sont décrites comme associées à une létalité importante. Nous avons réalisé le présent travail dans le but d’étudier ces complications chez les adultes hospitalisés dans les CHU de Ouagadougou durant l’épidémie de dengue de 2023, au Burkina Faso. Il s’est agi d’une étude transversale, rétrospective, descriptive et analytique, ayant concerné les cas confirmés de dengue chez des adultes hospitalisés du 1er janvier au 31 décembre 2023 dans les CHU de Ouagadougou. La fréquence des complications neurologiques de la dengue, les données sociodémographiques, cliniques, paracliniques et évolutives intrahospitalières de ces patients ont été analysées. Une analyse bivariée puis une étude multivariée selon la méthode de régression logistique multiple ont permis d’identifier les facteurs associés à la létalité intrahospitalière de ces patients. Au total, 1 057 patients ont été hospitalisés pour une dengue dans les CHU de Ouagadougou durant la période épidémique, dont 116 (11 %) ont présenté des complications neurologiques, avec un âge moyen de 47,6 ans et une prédominance féminine (51,7 %). Les troubles de la conscience, les crises épileptiques, les troubles psycho-comportementaux, dans respectivement 84,5 %, 20,7 % et 14,6 % des cas, étaient les signes cliniques neurologiques les plus fréquemment retrouvés. Les complications neurologiques rencontrées étaient les encéphalopathies (7,8 %), les encéphalites probablement dues à la dengue (0,8 %), les accidents vasculaires cérébraux (0,7 %) et le syndrome de Guillain-Barré (0,1 %). La létalité hospitalière a été de 69 % (80 patients) et l’insuffisance rénale aiguë a été le seul facteur indépendant qui lui a été associé (OR = 3,49; p = 0,02). Au Burkina Faso, les complications neurologiques de la dengue sont dominées par les encéphalopa-thies multifactorielles, grevées par une très lourde mortalité. Le dépistage et l’admission précoces dans les unités de soins intensifs ou de réanimation des patients ayant une dengue sévère (avec notamment des signes neurologiques), contribueraient à améliorer leur pronostic.
- Open Access
- 21 February 2025
- Vol. 5 (1)
Traitement et évolution clinique de la myasthénie auto-immune au Burkina Faso
En Afrique subsaharienne, la myasthénie auto-immune (MAI) est encore peu connue et sous diagnostiquée (retard diagnostique, faible disponibilité et faible accessibilité des moyens diagnostiques et thérapeutiques d'efficacité prouvée), d'où un pronostic fonctionnel péjoratif et une mortalité élevée. La présente étude a pour but d’évaluer les modalités thérapeutiques et évolutives cliniques de la MAI au Burkina Faso. Il s'agit d'une étude longitudinale et multicentrique, réalisée de mars 2015 à avril 2023. Elle a concerné les patients qui présentaient des signes cliniques évocateurs de myasthénie, associés à la présence dans le sérum d'anticorps (Ac) anti-récepteurs de l'acétylcholine (anti-RACh) et/ou d'Ac anti-Muscles Specific Kinase (anti-MuSK), et/ou à la présence d'un décrément >10 % à l’électroneuromyographie, et/ou avec un test thérapeutique positif aux anticholinesthérasiques oraux. Les données sur les modalités du traitement et les données évolutives cliniques ont été analysées grâce au logiciel Epi InfoTM 7.2.5.0. Une analyse bivariée avec calcul de la p-value (<0,05) a permis d'identifier les facteurs associés à l’évolution clinique défavorable. En tout, 40 patients atteints de MAI ont été colligés avec une prédominance féminine (60 %). La médiane d’âge de début était de 25 ans (IQ=7). Les délais médians de consultation neurologique et diagnostique étaient respectivement de 21 mois (IQ=12) et 22 mois (IQ=12). La maladie affectait des adultes jeunes dans 85 % des cas, et présentait une forme généralisée pour 35 cas. Respectivement 22 patients et 4 patients parmi 33 avaient des Ac anti-RACh et des Ac anti-MuSK. Une hyperplasie thymique et un thymome ont été trouvés chez 22 patients et 6 patients sur 38 à la TDM thoracique. Tous les patients ont reçu un traitement symptomatique par anticholinestérasiques oraux et 36 un traitement de fond par corticoïdes et/ou par immunosuppresseur (azathioprine). Quatre patients sur 9 ont eu une cure d'immunoglobulines intraveineuses (IgIV) ou des échanges plasmatiques (EP) pour crises myasthéniques. Une thymectomie a été réalisée chez 16 patients sur 40. À l'issue d'un suivi ambulatoire médian de 53 mois (IQ=16), sur les 40 patients retenus dans l’étude, 6 (soit 15 %) sont décédés, 14 (35 %) étaient en rémission clinique stable, et 17 (43 %) avaient une amélioration clinique partielle. Au Burkina Faso, la MAI souffre d'un retard diagnostique. La quasi-totalité des patients suivis pour MAI bénéficie d'un traitement par anticholinestérasiques et corticoïdes seuls, ou associés à l'azathioprine. Les IgIV, les EP et la thymectomie restent d'accessibilité limitée. La mortalité touche près d'un patient sur 6, et la rémission clinique stable ne concerne qu'environ un tiers des patients. Une amélioration du pronostic nécessite de rendre disponibles et accessibles les moyens diagnostiques et les traitements d'efficacité prouvée, tels la thymectomie, les immunosuppresseurs, les IgIV et les EP.
- 21 February 2025
- Vol. 5 (1)
Open AccessTraitement et évolution clinique de la myasthénie auto-immune au Burkina Faso
En Afrique subsaharienne, la myasthénie auto-immune (MAI) est encore peu connue et sous diagnostiquée (retard diagnostique, faible disponibilité et faible accessibilité des moyens diagnostiques et thérapeutiques d'efficacité prouvée), d'où un pronostic fonctionnel péjoratif et une mortalité élevée. La présente étude a pour but d’évaluer les modalités thérapeutiques et évolutives cliniques de la MAI au Burkina Faso. Il s'agit d'une étude longitudinale et multicentrique, réalisée de mars 2015 à avril 2023. Elle a concerné les patients qui présentaient des signes cliniques évocateurs de myasthénie, associés à la présence dans le sérum d'anticorps (Ac) anti-récepteurs de l'acétylcholine (anti-RACh) et/ou d'Ac anti-Muscles Specific Kinase (anti-MuSK), et/ou à la présence d'un décrément >10 % à l’électroneuromyographie, et/ou avec un test thérapeutique positif aux anticholinesthérasiques oraux. Les données sur les modalités du traitement et les données évolutives cliniques ont été analysées grâce au logiciel Epi InfoTM 7.2.5.0. Une analyse bivariée avec calcul de la p-value (<0,05) a permis d'identifier les facteurs associés à l’évolution clinique défavorable. En tout, 40 patients atteints de MAI ont été colligés avec une prédominance féminine (60 %). La médiane d’âge de début était de 25 ans (IQ=7). Les délais médians de consultation neurologique et diagnostique étaient respectivement de 21 mois (IQ=12) et 22 mois (IQ=12). La maladie affectait des adultes jeunes dans 85 % des cas, et présentait une forme généralisée pour 35 cas. Respectivement 22 patients et 4 patients parmi 33 avaient des Ac anti-RACh et des Ac anti-MuSK. Une hyperplasie thymique et un thymome ont été trouvés chez 22 patients et 6 patients sur 38 à la TDM thoracique. Tous les patients ont reçu un traitement symptomatique par anticholinestérasiques oraux et 36 un traitement de fond par corticoïdes et/ou par immunosuppresseur (azathioprine). Quatre patients sur 9 ont eu une cure d'immunoglobulines intraveineuses (IgIV) ou des échanges plasmatiques (EP) pour crises myasthéniques. Une thymectomie a été réalisée chez 16 patients sur 40. À l'issue d'un suivi ambulatoire médian de 53 mois (IQ=16), sur les 40 patients retenus dans l’étude, 6 (soit 15 %) sont décédés, 14 (35 %) étaient en rémission clinique stable, et 17 (43 %) avaient une amélioration clinique partielle. Au Burkina Faso, la MAI souffre d'un retard diagnostique. La quasi-totalité des patients suivis pour MAI bénéficie d'un traitement par anticholinestérasiques et corticoïdes seuls, ou associés à l'azathioprine. Les IgIV, les EP et la thymectomie restent d'accessibilité limitée. La mortalité touche près d'un patient sur 6, et la rémission clinique stable ne concerne qu'environ un tiers des patients. Une amélioration du pronostic nécessite de rendre disponibles et accessibles les moyens diagnostiques et les traitements d'efficacité prouvée, tels la thymectomie, les immunosuppresseurs, les IgIV et les EP.
- Open Access
- 13 December 2024
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 8
Anthropometric characteristics between ever and never screened for hypertension in Burkina Faso
Background: Excess body weight was associated with a higher chance for hypertension detection.Aim: To compare the anthropometric characteristics and blood pressure levels between Burkinabè adults who had ever been screened for hypertension and those who had never been screened, and to assess the associated factors with the uptake of hypertension screening.Setting: Urban and rural Burkina Faso.Methods: This was a secondary analysis using the Burkina Faso 2013 WHO Stepwise approach to Surveillance cross-sectional survey. Data from 3831 adult men and women were analysed. Descriptive and analytical analyses were performed using Student’s t, ANOVA, χ2, Fisher’s exact tests and logistic regression.Results: Among participants, 41.6% (95% CI: 40.0–43.1) had never been screened for hypertension, and compared to those who had ever been screened, they had significantly lower mean weight, waist circumference and body mass index, and lower prevalence of overweight or obesity and abdominal obesity. The prevalence of prehypertension was similar between the two groups (around 40%) and the prevalence of hypertension was lower in those who had never been screened (17.3% vs 20.8%; p = 0.007). Overweight or obesity (adjusted odds ratio [aOR] = 1.3; p = 0.03) and abdominal obesity (aOR = 1.3; p = 0.002) were associated with screening uptake.Conclusion: The Burkinabè adults who had never been screened for hypertension were apparently thin, but pre-hypertension or hypertension was also common among them. Increasing body size (excess weight or abdominal obesity) may be the reason for screening uptake.Contribution: Specific awareness-raising messages to motivate slim people to undergo screening need to be developed.
- 13 December 2024
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 8
Open AccessAnthropometric characteristics between ever and never screened for hypertension in Burkina Faso
Background: Excess body weight was associated with a higher chance for hypertension detection.Aim: To compare the anthropometric characteristics and blood pressure levels between Burkinabè adults who had ever been screened for hypertension and those who had never been screened, and to assess the associated factors with the uptake of hypertension screening.Setting: Urban and rural Burkina Faso.Methods: This was a secondary analysis using the Burkina Faso 2013 WHO Stepwise approach to Surveillance cross-sectional survey. Data from 3831 adult men and women were analysed. Descriptive and analytical analyses were performed using Student’s t, ANOVA, χ2, Fisher’s exact tests and logistic regression.Results: Among participants, 41.6% (95% CI: 40.0–43.1) had never been screened for hypertension, and compared to those who had ever been screened, they had significantly lower mean weight, waist circumference and body mass index, and lower prevalence of overweight or obesity and abdominal obesity. The prevalence of prehypertension was similar between the two groups (around 40%) and the prevalence of hypertension was lower in those who had never been screened (17.3% vs 20.8%; p = 0.007). Overweight or obesity (adjusted odds ratio [aOR] = 1.3; p = 0.03) and abdominal obesity (aOR = 1.3; p = 0.002) were associated with screening uptake.Conclusion: The Burkinabè adults who had never been screened for hypertension were apparently thin, but pre-hypertension or hypertension was also common among them. Increasing body size (excess weight or abdominal obesity) may be the reason for screening uptake.Contribution: Specific awareness-raising messages to motivate slim people to undergo screening need to be developed.
- Open Access
- 30 December 2023
- Published by Headache Medicine in Headache Medicine
- Vol. 14 (4) , 206-213
The Prevalence of migraine and associated factors among medical students in Ouagadougou (Burkina Faso)
Objective: To determine the prevalence, clinical characteristics and impact of migraine among medical students in the city of Ouagadougou. Methods: This across-sectional study was carried out during a period of 6 months from August 2021 to January 2022. Participants were selected by stratified random sampling according to academic level. Hetero-administered questionnaire was administred to each student. Migraine was diagnosed according to the ICHD 3rd edition criteria and the MIDAS was used to assess the impact of migraine on students' quality of life. Results: Two hundred and twenty seven students were selected for this study. The prevalence of migraineurs was 31.8%. Their mean age was 22.20±2.67 years. There was female predominance among the migraineurs (73.9%). More than half of the migraineurs had a family history of headache disorders (53.6%). Migraine without aura was the most frequent subtype (59.4%). Visual aura was predominant (78.2%). Migraine was of moderate intensity in 60.8% of cases. Insomnia and/or lack of sleep was the most common trigger (73.7%) followed by stress and fatigue in 71% of cases. Migraine caused severe disability in 15.9% of migraineurs. Conclusion: There was a high prevalence of migraine among medical students in Burkina Faso. Stress and irregular sleep were the most common triggers factors. Key words: prevalence, impact, migraine, medical student, Burkina Faso
- 30 December 2023
- Published by Headache Medicine in Headache Medicine
- Vol. 14 (4) , 206-213
Open AccessThe Prevalence of migraine and associated factors among medical students in Ouagadougou (Burkina Faso)
Objective: To determine the prevalence, clinical characteristics and impact of migraine among medical students in the city of Ouagadougou. Methods: This across-sectional study was carried out during a period of 6 months from August 2021 to January 2022. Participants were selected by stratified random sampling according to academic level. Hetero-administered questionnaire was administred to each student. Migraine was diagnosed according to the ICHD 3rd edition criteria and the MIDAS was used to assess the impact of migraine on students' quality of life. Results: Two hundred and twenty seven students were selected for this study. The prevalence of migraineurs was 31.8%. Their mean age was 22.20±2.67 years. There was female predominance among the migraineurs (73.9%). More than half of the migraineurs had a family history of headache disorders (53.6%). Migraine without aura was the most frequent subtype (59.4%). Visual aura was predominant (78.2%). Migraine was of moderate intensity in 60.8% of cases. Insomnia and/or lack of sleep was the most common trigger (73.7%) followed by stress and fatigue in 71% of cases. Migraine caused severe disability in 15.9% of migraineurs. Conclusion: There was a high prevalence of migraine among medical students in Burkina Faso. Stress and irregular sleep were the most common triggers factors. Key words: prevalence, impact, migraine, medical student, Burkina Faso
- Open Access
- 14 November 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-10
Geographical and sociodemographic disparities in fruit and vegetables consumption among adults in Burkina Faso: baseline results from the 2013 WHO STEPS survey
Background: Evidence on sociodemographic determinants and spatial variations in the fruit and/or vegetable (FV) consumption was reported. This study aimed to explore geographical and sociodemographic disparities in the level of FV consumption among adults in Burkina Faso, using the national baseline data. Methods: This was a cross-sectional secondary study of primary data obtained by the 2013 (September to October) World Health Organization Stepwise Approach to Surveillance survey conducted in Burkina Faso. The participants were 4402 women and men aged 25–64 years and living in all 13 Burkinabè Regions. Descriptive and analytical analyses were performed using Student’s t test, ANOVA, the chi-square test, Fisher’s exact test and logistic regressions. Results: The prevalence of a typical daily consumption of at least three servings was 4.1% (95% CI: 3.6–4.8) for fruits and 6.6% (95% CI: 5.9–7.3) for vegetables. The national prevalence of adequate FV intake was 5.1% (95% CI: 4.4–5.8), and for two Regions (“Centre-Ouest” and “Nord”) the pooled prevalence was 22.4%, while in the other eleven Regions its was significantly lower, 2.4% (p = 0.0001). Using quartiles derived from the national level of consumption, each of these two Regions had a higher proportion (about 50%) of their participants in the fourth quartile (the higher level). The associated sociodemographic factors with the adequate intake were being rural residents (aOR = 1.7, p = 0.011) and women (aOR = 1.3; p = 0.03). Conclusion: Except for the Regions of “Centre-Ouest” and “Nord” of Burkina Faso, the prevalence of adequate consumption of FV was very low in its other eleven Regions. Measures to increase consumption in urban people are urgent while women should be the key actor in the family-based approaches implementation and the nutrition education promoting FV consumption.
- 14 November 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-10
Open AccessGeographical and sociodemographic disparities in fruit and vegetables consumption among adults in Burkina Faso: baseline results from the 2013 WHO STEPS survey
Background: Evidence on sociodemographic determinants and spatial variations in the fruit and/or vegetable (FV) consumption was reported. This study aimed to explore geographical and sociodemographic disparities in the level of FV consumption among adults in Burkina Faso, using the national baseline data. Methods: This was a cross-sectional secondary study of primary data obtained by the 2013 (September to October) World Health Organization Stepwise Approach to Surveillance survey conducted in Burkina Faso. The participants were 4402 women and men aged 25–64 years and living in all 13 Burkinabè Regions. Descriptive and analytical analyses were performed using Student’s t test, ANOVA, the chi-square test, Fisher’s exact test and logistic regressions. Results: The prevalence of a typical daily consumption of at least three servings was 4.1% (95% CI: 3.6–4.8) for fruits and 6.6% (95% CI: 5.9–7.3) for vegetables. The national prevalence of adequate FV intake was 5.1% (95% CI: 4.4–5.8), and for two Regions (“Centre-Ouest” and “Nord”) the pooled prevalence was 22.4%, while in the other eleven Regions its was significantly lower, 2.4% (p = 0.0001). Using quartiles derived from the national level of consumption, each of these two Regions had a higher proportion (about 50%) of their participants in the fourth quartile (the higher level). The associated sociodemographic factors with the adequate intake were being rural residents (aOR = 1.7, p = 0.011) and women (aOR = 1.3; p = 0.03). Conclusion: Except for the Regions of “Centre-Ouest” and “Nord” of Burkina Faso, the prevalence of adequate consumption of FV was very low in its other eleven Regions. Measures to increase consumption in urban people are urgent while women should be the key actor in the family-based approaches implementation and the nutrition education promoting FV consumption.
- 27 March 2023
- Published by Elsevier in Revue Neurologique
- Vol. 179, S193
Morbi-mortalité des AVC au Burkina Faso
- 27 March 2023
- Published by Elsevier in Revue Neurologique
- Vol. 179, S193
Morbi-mortalité des AVC au Burkina Faso
- 25 December 2022
- Published by Scienceline Publication in World's Veterinary Journal
- p. 388-394
Seroprevalence and Associated Risk Factors of Porcine Cysticercosis in Boucle Du Mouhoun Region of Burkina Faso: A Cross-sectional Survey
Taenia solium cysticercosis is a neglected tropical zoonosis with economic and public health importance. Cysticercosis is widely present in low-income countries with extensive pig breeding systems and poor human hygiene practices. In Burkina Faso, a study on porcine cysticercosis has been done only in Boulkiemde province. There is a lack of serological data on this disease in other areas, such as Balés province in the Boucle du Mouhoun region. This study aimed to assess the prevalence and risk factors of porcine cysticercosis in Boucle du Mouhoun, Burkina Faso. A total of 373 serum samples were collected from local breed pigs that were randomly selected from four villages in the mentioned region. Data were also collected using a structured questionnaire to determine explanatory factors for the infection. Serum samples were tested using an antigen ELISA test to detect circulating antigens of Tænia solium. The prevalence of the disease was 54.9% (95% CI = 49.8-59.9). Following univariate and multivariate logistic regression analysis, pigs originating from Kombia were found to be a protective factor (OR=0.54, 95% CI = 0.33-0.89). Male pigs were more likely to be infected than females (OR= 1.7, 95% CI = 1.09-2.64). The prevalence and factors associated with Taenia solium cysticercosis were identified and according to these data, porcine cysticercosis had a high prevalence in this area. Therefore, it is important to implement control actions focusing on disease control and public health for people infected with Taenia solium.
- 25 December 2022
- Published by Scienceline Publication in World's Veterinary Journal
- p. 388-394
Seroprevalence and Associated Risk Factors of Porcine Cysticercosis in Boucle Du Mouhoun Region of Burkina Faso: A Cross-sectional Survey
Taenia solium cysticercosis is a neglected tropical zoonosis with economic and public health importance. Cysticercosis is widely present in low-income countries with extensive pig breeding systems and poor human hygiene practices. In Burkina Faso, a study on porcine cysticercosis has been done only in Boulkiemde province. There is a lack of serological data on this disease in other areas, such as Balés province in the Boucle du Mouhoun region. This study aimed to assess the prevalence and risk factors of porcine cysticercosis in Boucle du Mouhoun, Burkina Faso. A total of 373 serum samples were collected from local breed pigs that were randomly selected from four villages in the mentioned region. Data were also collected using a structured questionnaire to determine explanatory factors for the infection. Serum samples were tested using an antigen ELISA test to detect circulating antigens of Tænia solium. The prevalence of the disease was 54.9% (95% CI = 49.8-59.9). Following univariate and multivariate logistic regression analysis, pigs originating from Kombia were found to be a protective factor (OR=0.54, 95% CI = 0.33-0.89). Male pigs were more likely to be infected than females (OR= 1.7, 95% CI = 1.09-2.64). The prevalence and factors associated with Taenia solium cysticercosis were identified and according to these data, porcine cysticercosis had a high prevalence in this area. Therefore, it is important to implement control actions focusing on disease control and public health for people infected with Taenia solium.